Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $120.0M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.05 | $58.00K | 53.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2825 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 1430 | 3 |
View Market Depth
| Last trade - 15.46pm 23/07/2025 (20 minute delay) ? |
| CYC (ASX) Chart |